Trial Profile
A Phase Ib Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Entinostat (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 13 Jan 2021 Planned initiation date changed from 1 Nov 2020 to 1 Jan 2021.
- 13 Jan 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 24 Aug 2020 Planned initiation date changed from 1 Jul 2020 to 1 Nov 2020.